RELMADA THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Relmada Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q4 2024.
  • Relmada Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$19.1M, a 28.9% increase year-over-year.
  • Relmada Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$83.9M, a 19.1% increase year-over-year.
  • Relmada Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$83.9M, a 19.1% increase from 2023.
  • Relmada Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$104M, a 35.7% increase from 2022.
  • Relmada Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$161M, a 28.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$83.9M -$19.1M +$7.75M +28.9% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 -$91.6M -$23M -$316K -1.39% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$91.3M -$18.8M +$7.21M +27.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$98.5M -$23M +$5.17M +18.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$104M -$26.8M +$11.9M +30.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 -$116M -$22.7M +$16M +41.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$132M -$26M +$19.5M +42.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$151M -$28.2M +$10.1M +26.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$161M -$38.7M -$4.52M -13.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$157M -$38.7M +$3.92M +9.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$161M -$45.5M -$19.1M -72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$142M -$38.3M -$15.9M -70.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$126M -$34.2M -$13.3M -63.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$112M -$42.7M -$25.5M -148% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$87M -$26.5M -$13.7M -107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$73.3M -$22.4M -$12.4M -125% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$60.8M -$20.9M -$16.4M -358% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$44.5M -$17.2M -$13.5M -363% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$31M -$12.8M -$8.62M -208% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$22.4M -$9.97M -$7.27M -269% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$15.1M -$4.56M -$1.09M -31.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$14M -$3.71M -$1.3M -53.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$12.7M -$4.14M -$2.21M -114% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$10.5M -$2.7M -$152K -5.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$10.4M -$3.48M -$2.02M -139% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-13
Q3 2018 -$8.35M -$2.41M -$1.43M -146% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$6.92M -$1.93M -$147K -8.26% Apr 1, 2018 Jun 30, 2018 10-KT 2020-03-26
Q1 2018 -$6.77M -$2.55M -$267K -11.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.5M -$1.46M +$79.8K +5.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$6.58M -$981K +$636K +39.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$7.22M -$1.78M +$1.33M +42.8% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$8.55M -$2.28M +$464K +16.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$9.02M -$1.54M +$4.19M +73.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-12
Q3 2016 -$13.2M -$1.62M +$3.01M +65.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$16.2M -$3.12M +$1.3M +29.4% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 -$17.5M -$2.75M +$1.83M +40% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$19.3M -$5.72M -$1.34M -30.5% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 -$18M -$4.63M -$907K -24.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$17.1M -$4.41M Apr 1, 2015 Jun 30, 2015 10-K 2016-09-09
Q1 2015 -$4.58M -$3.87M -543% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.38M +$670K +13.3% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 -$3.72M -$3.24M -673% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 -$6.27M -$712K -$111K -18.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$6.16M -$5.06M -$5.05M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$1.11M -$482K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$19.5K -$17K Mar 1, 2013 May 31, 2013 10-Q 2013-07-12
Q1 2013 -$601K -$600K Jan 1, 2013 Mar 31, 2013 8-K 2014-05-27
Q4 2012 -$9.02K* Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q2 2012 -$2.48K* Mar 1, 2012 May 31, 2012 10-Q 2013-07-12
Q1 2012 -$503* Dec 1, 2011 Feb 29, 2012 10-Q 2013-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.